Welkom bij Stieren en Beren

Nauwkeurige informatie over marktaandelen. Bekijk aandelenkoersen, nieuws, financiële gegevens, grafieken en meer.

Stijgende aandelen

ALDOL.PADolfines SA0,00 US$66,67 %
XCURExicure, Inc.0,52 US$28,59 %
BITFBitfarms Ltd.2,59 US$21,03 %
ARBKArgo Blockchain plc1,86 US$20,00 %
GREEGreenidge Generation Holdings Inc.5,34 US$18,67 %
HCDIPHarbor Custom Development, Inc.1,28 US$17,43 %
PHE.LPowerHouse Energy Group Plc0,29 US$16,00 %
JANJanOne Inc.0,53 US$13,89 %

Dalende aandelen

HYREHyreCar Inc.0,02 US$-83,35 %
TRKATroika Media Group, Inc.0,34 US$-37,50 %
PEARPear Therapeutics, Inc.0,00 US$-20,00 %
MOBQMobiquity Technologies, Inc.0,14 US$-17,14 %
NOVASunnova Energy International Inc.10,41 US$-16,12 %
DLADelta Apparel, Inc.7,50 US$-15,45 %
BBIGVinco Ventures, Inc.0,01 US$-9,09 %
GRILMuscle Maker, Inc.1,01 US$-8,18 %

Markt nieuws

GE3 Wind Stocks to Buy for a Sustainable and Profitable Future - InvestorPlace
AKCCF3 Companies Leading the Charge in Carbon Capture Technology - InvestorPlace
RIVNRivian Had a Secret Advantage Nobody Knew About. Here's Why the Stock Is Still a Buy. - The Motley Fool
VRTXThe FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2 million per person - Business Insider
CBSTFTop Marijuana Stocks Gaining Ground in Early December 2023 - MarijuanaStocks
FTNTFrom $100 to $300: These 3 Stock Winners Won't Quit in 2024 - InvestorPlace
BTIBritish American Tobacco p.l.c. (BTI) Full Year 2023 Trading Update Conference Call (Transcript) - Seeking Alpha
MDLZMondelez: Buy This Tasty Treat For Growth & Dividends Combined - Seeking Alpha
MOIs Altria's 9%-Yielding Dividend Safe? - The Motley Fool
ACB2 Popular Stocks to Avoid Like the Plague in 2024 and Beyond - The Motley Fool
BACWho Actually Owns America's Biggest Oil Company? - 24/7 Wall Street
XLUXLU: Please Don't Wait Until The Fed Cuts Before Buying - Seeking Alpha
TWLOWill Twilio Be a Trillion-Dollar Stock by 2050? - The Motley Fool
LUVHow Southwest Contract Rejection Helps American Flight Attendants - Forbes
RIVNWho Actually Owns Rivian - 24/7 Wall Street
TCRXTScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition - GlobeNewsWire
CGBDCarlyle Secured Lending: An 11% Dividend And A 6.5-7.5% Yield On Debt - Seeking Alpha
FPFFPF: A Reasonable Way To Profit From Falling Interest Rates - Seeking Alpha
HUBSStock Split Watch: 2 Monster Growth Stocks Up 322% and 861% in 7 Years to Buy Now and Hold Long Term - The Motley Fool
AMDIs AMD the New AI Overlord? - The Dog of Wall Street